How to Select Recombinant CD Antigens for Flow Cytometry Antibody Screening
Recombinant CD antigens for flow cytometry should be selected according to the screening purpose, target topology, epitope type, species, expression host, construct boundaries and molecular format. Soluble extracellular domains can support antibody-binding, competition and bead-based screening, while antigen-positive cells or membrane-presented proteins provide a closer representation of cell-surface recognition. In this workflow, soluble recombinant CD antigens are generally immobilized on compatible beads or used as competition reagents. Direct cell-surface flow cytometry instead uses antigen-expressing cells or another membrane-presented target system. This distinction matters commercially as well as scientifically. A readily available soluble CD protein may be the most efficient reagent for early clone ranking, but a membrane-spanning target or conformation-dependent epitope may require a VLP, nanodisc, transfected cell or stable cell line for meaningful confirmation.
Beta LifeScience’s CD Proteins collection includes recombinant CD targets across human and multiple model species, expression systems and tag formats. Researchers can begin with a catalog product, evaluate supported semi-custom changes for an eligible protein or request fully custom production when the required construct is unavailable.

Featured Recombinant CD Antigens
The examples below show different CD-antigen formats that may support antibody-screening workflow development. Confirm the product’s current specifications, availability and suitability for the intended flow cytometry strategy before ordering.
|
CD antigen |
CAT# |
Listed format |
Potential screening role |
Key purchasing check |
Action |
|
Recombinant Human CD3E Protein |
BLC-11162P |
E. coli; residues 23–126; N-terminal His; extracellular domain |
Potential soluble-binding, competition or bead-capture use |
Confirm folding and epitope compatibility because bacterial expression does not provide glycosylation |
|
|
Recombinant Human CD70 Protein |
BLC-10853P |
Yeast; N-terminal His tag |
Format-dependent ligand-binding or antibody-screening evaluation |
Confirm oligomeric state, activity evidence and assay compatibility |
|
|
Biotinylated Recombinant Human CD22 Protein |
BLC-06356P |
Mammalian; His-Avi; protein fragment |
Directional bead capture and streptavidin-based screening |
Verify construct boundaries and completed biotinylation |
|
|
Recombinant Human CD46 Protein |
BLC-06355P |
Mammalian; His tag; protein fragment |
Soluble target-binding and competition studies |
Confirm domain coverage and epitope representation |
|
|
Biotinylated Recombinant Human CD69 Protein |
BLC-06529P |
E. coli; MBP/His-Avi; protein fragment |
Feasibility evaluation in a controlled bead-capture workflow |
Account for the MBP fusion, construct and host-dependent presentation |
Catalog prices, promotions and availability may change. Review the current product page and documentation when placing an order.
Quick Answer: Which CD-Antigen Format Should You Choose?
|
Screening objective |
Preferred starting format |
|
Rank antibodies by binding to a defined extracellular domain |
Soluble recombinant CD antigen |
|
Compare clones using a common bead-capture workflow |
Biotinylated or assay-compatible tagged CD antigen |
|
Test whether soluble antigen competes with cell-surface binding |
Soluble ECD matched to the suspected epitope |
|
Confirm recognition of native membrane topology |
Antigen-positive cells or a membrane-presented format |
|
Evaluate a multi-pass target such as CD20 |
VLP, nanodisc or cell-based presentation |
|
Compare human and model-species binding |
Matched ortholog constructs with aligned hosts and tags |
Use the simplest format that answers the current decision, then confirm promising antibodies in a more native target context.

Which Purchasing Route Fits Your Project?
|
Route |
Best suited for |
Buyer action |
|
Catalog CD antigen |
Available species, construct, host, tag and validation match the screen |
Purchase for feasibility, bead capture or competition work |
|
Semi-custom configuration |
An eligible protein needs a supported change to host, tag, isoform, variant, buffer, formulation, concentration, endotoxin or packaging |
|
|
Fully custom production |
The requested construct, ortholog, boundary, isoform or mutation falls outside supported semi-custom options |
The proposed expression, purification and analytical scope should be confirmed during technical evaluation.
Need help selecting a CD-antigen format?
Share the target, antibody format, screening method, species, preferred tag and required quantity for catalog-format review or custom feasibility evaluation.
Request CD-Antigen Selection Support
Understand the Role of Recombinant CD Antigens
Soluble extracellular domains
Soluble ECDs are practical for direct-binding studies, antibody pre-absorption, competition controls and bead-based screening. They provide a defined target concentration and can reduce dependence on variable cellular expression during early work. Their value depends on whether the antibody epitope is represented by the construct. Membrane-proximal, conformational or multi-pass epitopes may not be reproduced fully in a truncated soluble protein.
Antigen-coated or antigen-captured beads
Bead-based flow cytometry combines a defined recombinant antigen with single-particle fluorescence analysis. Biotinylated protein can be captured on streptavidin beads, while His-tagged proteins may be used with a compatible capture surface. Control antigen density because high loading can create avidity and make weak interactions appear stronger. Include blank beads, an irrelevant protein with the same tag and a positive-control antibody where available.
Membrane-presented proteins and antigen-positive cells
VLPs, nanodiscs and engineered cells can preserve features that soluble ECDs do not fully represent. Beta LifeScience’s VLP Transmembrane Proteins include challenging membrane targets such as CD20 alongside other oncology and immunology targets. VLP or nanodisc availability should be confirmed for the selected molecule. For direct cellular flow cytometry, researchers still need suitable antigen-positive cells and an appropriate cellular assay design.
Match Protein Architecture to the CD Target
CD antigens include single-pass receptors, ligands, adhesion proteins, enzymes and multi-pass membrane proteins. One recombinant format does not suit every target.
Single-pass CD proteins
Many single-pass targets can be represented by a soluble extracellular domain. Confirm that the construct includes the epitope-bearing region and relevant disulfide or glycosylation features.
Multi-pass CD proteins
Multi-pass targets such as CD20 depend heavily on membrane topology. A short peptide or isolated loop may support narrowly defined applications, while VLPs, nanodiscs or target-expressing cells generally provide a more relevant context for antibodies recognizing native extracellular loops.
Multimeric ligands and receptors
Some CD proteins function as dimers or higher-order complexes. Fc fusions or other multimeric formats may improve stability or presentation, but they can also increase avidity. Compare molecular format and expected biological organization before ordering.
Select Expression Host and Tag
Expression host
Mammalian expression is a strong starting choice for glycosylated CD antigens and conformational epitopes. Yeast, insect and bacterial systems can support suitable constructs; a bacterial fragment may suit a linear epitope, while native-like extracellular recognition may benefit from mammalian processing.
His-tagged proteins
His tags support purification, detection and compatible bead capture. Verify tag position and use an irrelevant His-tagged control to identify anti-tag or capture-surface interactions.
Avi-tagged and biotinylated proteins
Avi-tagged proteins support site-specific enzymatic biotinylation, but an Avi tag alone does not establish that biotinylation has been completed. For bead-based screening, confirm that the supplied product is biotinylated and review the labeling information.
Fc-tagged proteins
Fc fusions can improve stability and dimerization. They may also bind Fc receptors or anti-Fc detection reagents, creating background in immune-cell assays. Use Fc-only controls and an assay design that distinguishes the target antigen from the fusion partner.

Build a Focused Antibody-Screening Workflow
A practical workflow can progress from defined recombinant antigen to cellular confirmation:
- Confirm antibody binding to the selected recombinant CD antigen.
- Rank clones using consistent antigen loading and concentration ranges.
- Use soluble antigen competition to investigate target-dependent binding.
- Test leading clones on antigen-positive and antigen-negative cells.
- Add species orthologs, isoforms or related-family proteins where relevant.
- Confirm functional effects in an application-specific assay when required.
This staged design uses recombinant proteins efficiently without asking a soluble reagent to reproduce every feature of a cell membrane.

Use Controls That Match the CD-Antigen Format
For cell-based screening, include antigen-negative cells, a positive-control antibody and a viability dye. For bead-based screening, use blank beads and an irrelevant protein carrying the same tag. These format-specific controls distinguish target binding from cellular, bead-surface or tag-dependent background. Multicolor panels also require appropriate compensation and fluorescence-minus-one controls.
QC and Documentation to Review Before Ordering
|
Purchasing check |
What to confirm |
Why it matters |
|
Target identity |
CD name, gene symbol, species and isoform |
Prevents selection by an ambiguous marker name |
|
Construct |
Sequence range and ECD coverage |
Determines whether the epitope may be present |
|
Expression host |
Mammalian, yeast, insect or bacterial |
Influences folding and post-translational processing |
|
Tag and position |
His, Avi, Fc or another format |
Determines capture strategy and possible background |
|
Biotinylation |
Completed labeling and available documentation |
Supports controlled streptavidin-bead capture |
|
Purity and aggregation |
Analytical method and lot-specific result |
Supports consistent antigen loading |
|
Binding or activity |
Test method for the supplied format |
Provides evidence of product performance in a defined assay |
|
Formulation |
Buffer, carrier and stabilizers |
Affects bead coupling, dilution and storage |
|
Endotoxin |
Published limit when relevant |
Important for cell-based or functional follow-up |
|
Supply status |
Pack size, price, availability and lead time |
Supports budget and study scheduling |
Requested identity, purity, aggregation, binding, activity or specialized testing should be discussed and confirmed in the quotation. Do not assume that every analytical method is included with each catalog or custom protein. Estimate quantity from bead number, antigen loading, clone count, titration points, controls and repeats, including material for coupling optimization. Longer campaigns may benefit from bulk or dedicated-lot planning; bridge new lots with the same antibody panel and loading conditions.
Prepare a Quote-Ready CD-Antigen Request
Provide:
- CD target, gene symbol, species, sequence and boundaries
- Known epitope or domain, if available
- Preferred host, tag and soluble or membrane-presented format
- Flow cytometry, bead-screening or competition-assay design
- Purity, aggregation, activity and endotoxin expectations
- Quantity, formulation, packaging and timeline
These details allow the technical team to compare catalog, eligible semi-custom and fully custom routes without assuming that every CD antigen requires the same production strategy.
Request CD-Antigen Support for Antibody Screening
Browse the CD Proteins collection, or submit the target, construct, format, assay workflow, quantity and QC expectations for catalog, semi-custom or custom evaluation.
Request Recombinant CD-Antigen Selection and a Quote
FAQs
Can soluble recombinant CD antigens be analyzed directly by flow cytometry?
Soluble proteins are commonly attached to assay-compatible beads or used as competition reagents. Direct cell-surface flow cytometry requires cells expressing the target or another membrane-presented system.
Should I choose a soluble ECD or full-length membrane target?
Choose a soluble ECD for defined extracellular binding, competition and bead-based screening. Use a membrane-presented format when topology, extracellular loops or native-like context are central to the epitope.
Why use a biotinylated CD antigen for bead screening?
Biotinylated protein can support controlled capture on streptavidin beads. Confirm completed biotinylation, construct boundaries and antigen-loading conditions before comparing clones.
What controls are most important for cell-based antibody screening?
Use antigen-negative cells, a positive-control antibody, viability dye and appropriate fluorescence controls. Secondary-only or isotype controls may also support interpretation depending on the staining design.
When should I request custom CD-antigen production?
Request custom production when the catalog does not provide the required species, isoform, ECD boundary, mutation, tag or membrane-presented format, or when a matched antigen panel is needed.